Salem Investment Counselors’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.5K Hold
2,250
﹤0.01% 682
2026
Q1
$32.3K Buy
+2,250
New +$33.4K ﹤0.01% 683
2025
Q4
Sell
-2,250
Closed -$32.4K 481
2025
Q3
$32.4K Sell
2,250
-753
-25% -$10.7K ﹤0.01% 675
2025
Q2
$42.8K Hold
3,003
﹤0.01% 608
2025
Q1
$44.7K Hold
3,003
﹤0.01% 595
2024
Q4
$43.2K Hold
3,003
﹤0.01% 603
2024
Q3
$47.6K Sell
3,003
-374
-11% -$5.9K ﹤0.01% 590
2024
Q2
$51.9K Buy
+3,377
New +$51.2K ﹤0.01% 548

Other funds holding BMEZ

Salem Investment Counselors's BMEZ Position: Q2 2026 in Review

Salem Investment Counselors held its BlackRock Health Sciences Trust II (BMEZ) position steady in Q2 2026 at 2,250 shares worth $34.5K. The position accounts for ﹤0.01% of the portfolio, ranked #682.

Salem Investment Counselors first reported a position in BMEZ in Q2 2024 and has held it in 8 quarters since. The position peaked at $51.9K in Q2 2024. 31 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

  • Salem Investment Counselors held 2,250 shares of BlackRock Health Sciences Trust II worth $34.5K as of Q2 2026.
  • Salem Investment Counselors left its BlackRock Health Sciences Trust II share count unchanged in Q2 2026.
  • BlackRock Health Sciences Trust II made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #682 holding.
  • Salem Investment Counselors first reported a position in BlackRock Health Sciences Trust II in Q2 2024 and has held it in 8 quarters since.
  • Salem Investment Counselors's BlackRock Health Sciences Trust II position peaked at $51.9K in Q2 2024.
  • 31 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.